A detailed history of Epoch Investment Partners, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 8,391 shares of NVS stock, worth $927,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,391
Previous 8,436 0.53%
Holding current value
$927,708
Previous $816,000 9.44%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $4,165 - $4,831
-45 Reduced 0.53%
8,391 $893,000
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $2,286 - $2,603
-24 Reduced 0.28%
8,436 $816,000
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $74,830 - $82,348
811 Added 10.6%
8,460 $854,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $26,619 - $29,541
-281 Reduced 3.54%
7,649 $779,000
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $79,104 - $89,698
-855 Reduced 9.73%
7,930 $800,000
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $22,888 - $26,543
-286 Reduced 3.15%
8,785 $808,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $15,865 - $19,429
-210 Reduced 2.26%
9,071 $822,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $8,281 - $9,685
111 Added 1.21%
9,281 $705,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $60,712 - $70,687
754 Added 8.96%
9,170 $775,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $411,765 - $465,786
5,140 Added 156.9%
8,416 $738,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $261,097 - $288,713
3,276 New
3,276 $287,000
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $186,131 - $216,538
-2,276 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $8,353 - $9,226
-98 Reduced 4.13%
2,276 $208,000
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $12,441 - $14,672
149 Added 6.7%
2,374 $203,000
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $173,705 - $210,106
2,225 New
2,225 $210,000
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $287,490 - $318,500
-3,500 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $31,643 - $35,620
-391 Reduced 10.05%
3,500 $306,000
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $44,804 - $62,772
-634 Reduced 14.01%
3,891 $321,000
Q4 2019

Feb 13, 2020

SELL
$84.35 - $95.37 $64,780 - $73,244
-768 Reduced 14.51%
4,525 $428,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $18,048 - $19,888
-211 Reduced 3.83%
5,293 $460,000
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $12,742 - $15,683
169 Added 3.17%
5,504 $503,000
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $26,060 - $29,807
-346 Reduced 6.09%
5,335 $513,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $20,477 - $22,801
-278 Reduced 4.67%
5,681 $487,000
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $53,217 - $61,556
-795 Reduced 11.77%
5,959 $513,000
Q2 2018

Aug 13, 2018

SELL
$64.91 - $73.36 $55,952 - $63,236
-862 Reduced 11.32%
6,754 $510,000
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $3,589 - $4,291
-51 Reduced 0.67%
7,616 $616,000
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $7,883 - $8,462
-109 Reduced 1.4%
7,667 $644,000
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $576,512 - $600,851
7,776
7,776 $668,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.